Literature DB >> 22995898

NPP4 is a procoagulant enzyme on the surface of vascular endothelium.

Ronald A Albright1, William C Chang, Donna Robert, Deborah L Ornstein, Wenxiang Cao, Lynn Liu, Meredith E Redick, J Isaac Young, Enrique M De La Cruz, Demetrios T Braddock.   

Abstract

Ap3A is a platelet-dense granule component released into the extracellular space during the second wave of platelet aggregation on activation. Here, we identify an uncharacterized enzyme, nucleotide pyrophosphatase/phosphodiesterase-4 (NPP4), as a potent hydrolase of Ap3A capable of stimulating platelet aggregation and secretion. We demonstrate that NPP4 is present on the surface of vascular endothelium, where it hydrolyzes Ap3A into AMP and ADP, and Ap4A into AMP and ATP. Platelet aggregation assays with citrated platelet-rich plasma reveal that the primary and secondary waves of aggregation and dense granule release are strongly induced by nanomolar NPP4 in a concentration-dependent manner in the presence of Ap3A, while Ap3A alone initiates a primary wave of aggregation followed by rapid disaggregation. NPP2 and an active site NPP4 mutant, neither of which appreciably hydrolyzes Ap3A, have no effect on platelet aggregation and secretion. Finally, by using ADP receptor blockade we confirm that NPP4 mediates platelet aggregation via release of ADP from Ap3A and activation of ADP receptors. Collectively, these studies define the biologic and enzymatic basis for NPP4 and Ap3A activity in platelet aggregation in vitro and suggest that NPP4 promotes hemostasis in vivo by augmenting ADP-mediated platelet aggregation at the site of vascular injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995898      PMCID: PMC4017314          DOI: 10.1182/blood-2012-04-425215

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Ultraviolet absorption spectra of adenosine-5'-triphosphate and related 5'-ribonucleotides.

Authors:  R M BOCK; N S LING; S A MORELL; S H LIPTON
Journal:  Arch Biochem Biophys       Date:  1956-06       Impact factor: 4.013

2.  Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterization.

Authors:  J Lüthje; A Ogilvie
Journal:  Eur J Biochem       Date:  1987-12-01

3.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

4.  Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood.

Authors:  J Lüthje; J Baringer; A Ogilvie
Journal:  Blut       Date:  1985-12

5.  Isolation and characterization of dinucleoside tetra- and tri-phosphates formed in the presence of lysyl-sRNA synthetase.

Authors:  K Randerath; C M Janeway; M L Stephenson; P C Zamecnik
Journal:  Biochem Biophys Res Commun       Date:  1966-07-06       Impact factor: 3.575

Review 6.  Nucleotide receptor signaling in platelets.

Authors:  B N Kahner; H Shankar; S Murugappan; G L Prasad; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2006-11       Impact factor: 5.824

7.  Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.

Authors:  Lauren P Saunders; Wenxiang Cao; William C Chang; Ronald A Albright; Demetrios T Braddock; Enrique M De La Cruz
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

8.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.

Authors:  Silvia Jansen; Cristiana Stefan; John W M Creemers; Etienne Waelkens; Aleyde Van Eynde; Willy Stalmans; Mathieu Bollen
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

9.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

Review 10.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12
View more
  16 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

2.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of Enpp6.

Authors:  Junko Morita; Kazuki Kato; Emiko Mihara; Ryuichiro Ishitani; Junichi Takagi; Hiroshi Nishimasu; Junken Aoki; Osamu Nureki
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-05-24       Impact factor: 1.056

3.  Comparative genomic and expression analysis of the adenosine signaling pathway members in Xenopus.

Authors:  Alice Tocco; Benoît Pinson; Pierre Thiébaud; Nadine Thézé; Karine Massé
Journal:  Purinergic Signal       Date:  2014-10-16       Impact factor: 3.765

4.  Increased Ap4A levels and ecto-nucleotidase activity in glaucomatous mice retina.

Authors:  María J Pérez de Lara; Ana Guzmán-Aranguez; Rosa Gómez-Villafuertes; Javier Gualix; María Teresa Miras-Portugal; Jesús Pintor
Journal:  Purinergic Signal       Date:  2018-06-08       Impact factor: 3.765

5.  Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Authors:  Juan-Jose Garcés; Michal Simicek; Marco Vicari; Lucie Brozova; Leire Burgos; Renata Bezdekova; Diego Alignani; Maria-Jose Calasanz; Katerina Growkova; Ibai Goicoechea; Xabier Agirre; Ludek Pour; Felipe Prosper; Rafael Rios; Joaquin Martinez-Lopez; Pamela Millacoy; Luis Palomera; Rafael Del Orbe; Albert Perez-Montaña; Sonia Garate; Laura Blanco; Marta Lasa; Patricia Maiso; Juan Flores-Montero; Luzalba Sanoja-Flores; Zuzana Chyra; Alexander Vdovin; Tereza Sevcikova; Tomas Jelinek; Cirino Botta; Halima El Omri; Jonathan Keats; Alberto Orfao; Roman Hajek; Jesus F San-Miguel; Bruno Paiva
Journal:  Leukemia       Date:  2019-10-08       Impact factor: 11.528

6.  Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.

Authors:  Lauren E Ragle; Dilip J Palanisamy; Margaux J Joe; Rachel S Stein; Derek D Norman; Gabor Tigyi; Daniel L Baker; Abby L Parrill
Journal:  Bioorg Med Chem       Date:  2016-08-04       Impact factor: 3.641

Review 7.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

8.  Tanshinones induce tumor cell apoptosis via directly targeting FHIT.

Authors:  Xianglian Zhou; Yuting Pan; Yue Wang; Bojun Wang; Yu Yan; Yi Qu; Xisong Ke
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

9.  Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy.

Authors:  Sang-Yong Lee; Vigneshwaran Namasivayam; Nader M Boshta; Arianna Perotti; Salahuddin Mirza; Silvia Bua; Claudiu T Supuran; Christa E Müller
Journal:  RSC Med Chem       Date:  2021-06-16

10.  Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization.

Authors:  Nathan D Maulding; Dillon Kavanagh; Kristin Zimmerman; Gianfilippo Coppola; Thomas O Carpenter; Nathaniel K Jue; Demetrios T Braddock
Journal:  Bone       Date:  2020-09-24       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.